SCHEMBL8247057

SCHEMBL8247057

O=C(NC[C@@H]1CC(=O)N(c2ccc(N3CC[S+]([O-])CC3)c(F)c2)C1)c1ccc(Cl)s1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8238980 0.89 F10 (0.76) F10
SCHEMBL8240339 0.88 F10 (0.77) F10
SCHEMBL8248614 0.88 F10 (0.77) F10
SCHEMBL78885 0.87 F10 (0.83) F10
SCHEMBL8214902 0.85 F10 (0.76) F10
SCHEMBL8248467 0.80 F10 (0.74) F10
SCHEMBL13479666 0.79 F10 (0.80) F10
SCHEMBL8245918 0.77 F10 (0.55) F10
SCHEMBL8210599 0.77 F10 (0.55) F10
SCHEMBL5482932 0.77 F10 (0.72) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411932-B1 SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY BAYER SCHERING PHARMA AG (DE) 2010-02-10 — — EP disclosed
WO-2007042146-A1 MICROANGIOPATHY TREATMENT AND PREVENTION BAYER HEALTHCARE AG (DE) 2007-04-19 — — WO disclosed
WO-2003000256-A1 SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY BAYER HEALTHCARE AG (DE) 2003-01-03 — — WO disclosed
Send feedback